Cost-effectiveness Analysis of Rivaroxaban in the Secondary Prevention of Acute Coronary Syndromes in Sweden

por Begum, Najida, Stephens, Stephanie, Schoeman, Olaf, Fraschke, Anina, Kirsch, Bodo, Briere, Jean-Baptiste, Verheugt, Freek W. A., van Hout, Ben A.
Publicado 2015